thumbnail_10-10 copy
thumbnail_5-5 copy
thumbnail_10-5 copy
thumbnail_5-10 copy
thumbnail_10-10 copy
thumbnail_5-5 copy
thumbnail_10-5 copy
thumbnail_5-10 copy

Ancavaz

Pharmaceutical

Product Details:

Brand Name: Ancavaz Tablet

Composition

Each Ancavaz 10/10 mg Film tablet contains:

Amlodipine besylate / Perindopril arginine ........................................................ 10 mg/ 10 mg

Each Ancavaz 5/5 mg Film tablet contains:

Amlodipine besylate / Perindopril arginine ...................................................... 5 mg/ 5 mg

Each Ancavaz 5/5 mg Film tablet contains:

Amlodipine besylate / Perindopril arginine .................................................. 5 mg/ 10 mg.

Each Ancavaz 5/5 mg Film tablet contains:

Amlodipine besylate / Perindopril arginine ........................................10 mg/5mg.

Therapeutic Indications:                 

  • As substitution therapy for the treatment of hypertension and/or
  • Stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. Treatment should not be initiated with this combination.

Dosage and Administration:   

  • Recommended treatment is one tablet per day as a single dose, preferably to be taken in the morning and before a meal.

Contraindications:        

  • In patients with a history of previous hypersensitivity to either of the active ingredients; perindopril or amlodipine, ACE inhibitors, dihydropyridines or excipient ingredients
  • During pregnancy and for lactating women.

Warnings and precautions:           

  • Lactose intolerance.
  • Hyperkalaemia.
  • Patients with diabetes.
  • Lithium.
  • Potassium sparing medicines, potassium supplements or potassium-containing salt.

substitutes.

  • Dantrolene
  • Angioedema
  • Anaphylactoid reactions during low-density lipoproteins (LDL) apheresis and haemodialysis
  • Anaphylactic reactions during desensitization
  • Hypotension
  • Renovascular hypertension
  • Kidney transplantation
  • Dual blockade of the renin-angiotensin-aldosterone system (RAAS)
  • Proteinuria
  • Aortic or mitral valve Stenosis / hypertrophic cardiomyopathy
  • Primary aldosteronism.

Undesirable Effects:      

  • oedema,
  • somnolence,
  • dizziness,
  • headache

Pharmacological Properties:       

Ancavaz contains perindopril arginine, an angiotensin-converting enzyme inhibitor, and amlodipine, a dihydropyridine calcium channel blocker.

Packaging:               

Ancavaz 10/10mg Tablet : Box containing 2 blisters of 10 tablets each.

Ancavaz 5/5mg Tablet : Box containing 2 blisters of 10 tablets each.

Ancavaz 5/10mg Tablet : Box containing 2 blisters of 10 tablets each.

Ancavaz 10/5mg Tablet : Box containing 2 blisters of 10 tablets each.